Company Executives

$RNAZ Management Team

Dr. Daniel Vlock

Chief Medical Officer

Age -

Compensation -

Sex Male

Dr. Philippe Calais

Executive Chairman of the Board

Chief Executive Officer

Age 66

Compensation $112.6K USD

Sex Male

Mr. Thomas Fitzgerald

Chief Financial Officer

Vice President

Director

Age 74

Compensation $957.0K USD

Sex Male

Name / Title	Age	Compensation	Sex
Dr. Daniel Vlock Chief Medical Officer	-	-	Male
Dr. Philippe Calais Executive Chairman of the Board Chief Executive Officer	66	$112.6K USD	Male
Mr. Thomas Fitzgerald Chief Financial Officer Vice President Director	74	$957.0K USD	Male

Board of Directors

From the proxy statement filed Jun 2, 2026

Directors

serving now

Independent

4 of 6

stated in the proxy

Average tenure

4.8 years

from year joined

CEO also chairs the board

Yes

Philippe P. Calais, PharmD, PhD

Director	Age	On board	Independent	Committees	Other public boards	Pay
Philippe P. Calais, PharmD, PhD Board chair, CEO	67	2018 8 years	Not independent	None stated	None stated	Paid as CEO
Elizabeth Czerepak	70	2025 1 year	Independent	Audit Committee · Chair Compensation Committee	Delcath Systems Inc.	Not stated
Thomas A. Fitzgerald Executive officer	75	2018 8 years	Not independent	None stated	None stated	Not stated
Erik Manting, PhD	54	2020 6 years	Independent	Nominating and Corporate Governance Committee · Chair Audit Committee	None stated	Not stated
Magda Marquet, PhD	67	2021 5 years	Independent	Nominating and Corporate Governance Committee	Arcturus Therapeutics, First Tracks Therapeutics, Immix BioPharma	Not stated
Jack E. Stover	73	2025 1 year	Independent	Audit Committee Nominating and Corporate Governance Committee	Traws Pharma, Inc., Profusa, Inc.	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Jun 2, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$RNAZ Management Team

Dr. Daniel Vlock

Dr. Philippe Calais

Mr. Thomas Fitzgerald

Board of Directors

Related-party transactions

No related-party transactions disclosed